about
A review of structural neuroimaging in schizophrenia: from connectivity to connectomicsMetabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studiesIn vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophreniaNeurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysisT2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.Neurobiological background of negative symptoms.Psychoradiology: The Frontier of Neuroimaging in Psychiatry.Electroconvulsive therapy-induced brain functional connectivity predicts therapeutic efficacy in patients with schizophrenia: a multivariate pattern recognition studyA schizophrenia risk gene, ZNF804A, is associated with brain white matter microstructure.Diffusion tensor tractography findings in schizophrenia across the adult lifespanGlutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.Reduced left uncinate fasciculus fractional anisotropy in deficit schizophrenia but not in non-deficit schizophrenia.Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.Diffusion magnetic resonance imaging for Brainnetome: a critical reviewMultimodal functional and structural imaging investigations in psychosis research.Fiber pathway pathology, synapse loss and decline of cortical function in schizophreniaWhite matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study.The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study.Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.Cerebral Response to Peripheral Challenge with a Viral Mimetic.Diffuse abnormality of low to moderately organized white matter in schizophrenia.Glutamate and dopamine in schizophrenia: an update for the 21st centuryDisconnection Between Amygdala and Medial Prefrontal Cortex in Psychotic Disorders.Altered interhemispheric and temporal lobe white matter microstructural organization in severe chronic schizophrenia.A Neuregulin-1 schizophrenia susceptibility variant causes perihippocampal fiber tract anomalies in healthy young subjects.Revisiting the diagnosis of schizophrenia: where have we been and where are we going?Childhood trauma and schizotypy: a systematic literature review.Primary, Enduring Negative Symptoms: An Update on Research.Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophreniaThe common variants implicated in microstructural abnormality of first episode and drug-naïve patients with schizophrenia.Parietal lobes in schizophrenia: do they matter?Olig2 Silence Ameliorates Cuprizone-Induced Schizophrenia-Like Symptoms in Mice.Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?Peripheral immune challenge with viral mimic during early postnatal period robustly enhances anxiety-like behavior in young adult rats.Clozapine use in treatment-resistant agitation in the setting of dementia.Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex.Relationship Between Persistent Negative Symptoms and Findings of Neurocognition and Neuroimaging in Schizophrenia.
P2860
Q21558428-51CBC907-ABD9-4405-894E-EB6CEAC53EFDQ26865740-4788F1B8-7E72-4F25-AB2A-B4EB70C82CD0Q28083121-B9684C40-4FC4-4133-A5D3-EE2573612373Q30565982-BADD6289-1AE3-4087-AAB6-DC3068A2DA51Q30648464-6524E035-E73F-4643-8398-621B3D200B48Q30685335-58708844-6941-4DFF-8E5B-4C22F1B9F7DAQ30712278-99BA0C19-7FA0-4B7A-9101-F4683033C380Q30732395-3EC0C215-F909-4B03-B5FD-5A1A1E7BA237Q30913824-172D30B9-B26B-4FD0-966A-427DF0760EF6Q31137558-1A4A9F4B-5FB6-4075-A6BC-8479A3C78F19Q33718917-9B6ED3F2-E465-4C96-B189-80A9EC89A6C7Q33768413-CBA9BFAF-D8A3-48BF-822F-316B15EC5193Q33808386-6BD15CAD-2696-4F4F-9C5E-E0B49BA0C057Q33957510-2DB9FE17-E2E8-43B1-92F5-BE13117C7CABQ34129176-F00B4203-3931-482E-8FA4-01593B24C135Q34193383-8B623042-811C-4A71-B7AF-21E8638D217DQ34351901-559AF9D9-135F-47F2-AC08-7986301FF9CBQ34400977-9E42515D-4EEE-498D-A2D0-02DD77F532F5Q34673324-EF87F8D2-555B-47F0-8338-96B6EB26FB8CQ35932602-01A3F2AF-5E25-408F-B7D7-EFAC0E3D1ED5Q36184932-AC232289-95FC-4C42-8C64-9E8A3D768AE6Q36378169-BB718CCB-846C-4938-B19A-29CFB67205CCQ36642774-577D5B67-23BD-41D3-B5C4-158DF658125AQ36706252-C4E8C10A-4529-4709-810B-A5BE22C72707Q36992322-365DB605-84B3-4A98-8A18-F588A16385B2Q36994880-C7EFF54F-0E2C-4E4F-8A3C-69A1785D7CC4Q37584245-1230303D-F556-4A12-A02D-4CF4BC96BA9DQ37668038-84AD79F2-7993-4464-9DAC-D83147A5048FQ37825634-FD6F177E-D1A0-4598-BF67-A8ACE6CDB56EQ38255896-07D307FD-C4EE-466E-BADB-E8BDC2F2C17AQ38675564-0C8E43CE-FC03-4734-9C1C-EDA9F2ADD091Q41197010-AFAF26A7-A2BE-4660-AD81-B9F2DFDFA3E1Q41717795-0E684AB6-3306-4201-B63C-5006AEA20643Q42279142-1FB05119-ABDD-4815-BC31-245855011311Q42379391-1CF6E6BA-6D3A-43D5-8267-E235DCE187A1Q42544021-B0BD7E6D-2046-4AC8-8AD6-B46E84B355C6Q44966467-DB02AD44-CB77-40E7-9129-686C2C2A6CB6Q45967799-A4FF812E-66C1-4D45-B43F-160078C9AE73Q47301377-FF02485A-3AC8-4A50-93C9-4D94431D54A0Q47574520-D96ED645-34ED-4BD4-91F6-F68ADE59084E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
White matter alterations in deficit schizophrenia.
@en
White matter alterations in deficit schizophrenia.
@nl
type
label
White matter alterations in deficit schizophrenia.
@en
White matter alterations in deficit schizophrenia.
@nl
prefLabel
White matter alterations in deficit schizophrenia.
@en
White matter alterations in deficit schizophrenia.
@nl
P2093
P2860
P356
P1476
White matter alterations in deficit schizophrenia
@en
P2093
Alan Francis
Elena A Spieker
Peter B Barker
Robert W Buchanan
William T Carpenter
P2860
P2888
P304
P356
10.1038/NPP.2008.207
P407
P577
2008-12-03T00:00:00Z